Watch Our Latest Webinar – Customer Relationships Unmasked: Keeping Your Distance And Your Influence.


17 results for Medical Device

The Medical Device Approval Process

This module describes the FDA's risk-based classification and controls system and premarket submission options that define each medical device's particular regulatory path to demonstrate safety and effectiveness.

Today’s Medical Groups and the Transition to Value-Based Care (Medical Device and Diagnostics)

This module discusses the trends affecting medical groups and how medical device companies can build more meaningful partnerships with these important customers to help protect market access.

The Affordable Care Act and Its Implications for the Medical Device and Diagnostics Industry (Medical Device and Diagnostics)

Healthcare reform became a reality with passage of the Affordable Care Act (ACA) in 2010, and in June of 2012, when it was upheld by the US Supreme Court. Since then, however, it has faced continued challenges. This module looks at the main aspects of healthcare reform set forth by the ACA, including expanding access to insurance coverage, taxing medical devices (a provision that was repealed), and improving transparency between the industry and physicians. The module also explores the implications of these reforms for the MD&D industry.

Population Health Management: A Strategy for Higher Quality and Lower Costs (Medical Device and Diagnostics)

This module outlines current approaches to population health management, including patient-centered medical homes (PCMHs), perioperative surgical homes (PSHs), and accountable care organizations (ACOs). The module also discusses the implications of population health management for medical device and diagnostic (MD&D) companies.

EHRs and Health Information Technology: Opportunities for Medical Device and Diagnostic Sales and Marketing

As healthcare reform advances, health information technology (HIT) and initiatives aimed at health information exchange (HIE) are at its core. This module looks at how legislation set the wheels in motion. It explores how the use of HIT is being fueled by the adoption of “meaningful use” (now known as “promoting interoperability”) certified electronic health records (EHRs) and discusses the challenges associated with implementing EHRs. This module also clarifies the difference between EHRs and electronic medical records (EMRs), which arrived on the scene in many clinical practices before the nationwide commitment to EHRs.

Strategies for Effective Account Management (Medical Device and Diagnostics)

Although individual physicians remain an important target for medical device & diagnostic (MD&D) companies, many firms are putting greater emphasis on their key accounts, such as large, integrated delivery networks (IDNs) and accountable care organizations (ACOs). This module explores the activities that are essential to effective account management.

The Role of Accountable Care Organizations and Future Healthcare Delivery (Medical Device and Diagnostics)

Accountable care organizations (ACOs) are a key component of healthcare reform. This module covers the establishment of accountable care organizations and explores their potential impact on medical device and diagnostic (MD&D) companies.

Measuring the Patient Experience: The Connection to Quality (Medical Device and Diagnostics)

More than ever before, providers in a variety of settings are investing time and resources to evaluate their patients’ experience of care. Improving the patient experience is part of the “Triple Aim,” and how patients rate their experience is an increasingly important metric in pay-for-performance programs like Medicare’s Value-Based Purchasing (VBP) program. This module describes how providers are measuring and trying to improve the patient experience. Sales representatives will gain insight into how they can support their customers in these efforts.

The Health Insurance Marketplace (Medical Device and Diagnostics)

Healthcare reform established a new way to shop for private insurance—the Health Insurance Marketplace. This module looks at the main features of the market and how state health insurance exchanges are evolving amid political uncertainty. The module also explores the implications of exchanges for various stakeholders, including MD&D companies.

Major Healthcare Payers and Managed Care Payment (Medical Device and Diagnostics)

This module provides an overview of the major payers and payment arrangements. As payers continue to try and contain healthcare costs, they are shifting from traditional indemnity or fee-for-service payment arrangements with providers to various risk-based arrangements, including capitation, bundled payment, and shared savings. Many of these arrangements—which are sometimes called value-based payment—also incentivize providers to improve clinical quality and the patient experience.

Population Health Management: A Strategy for Higher Quality and Lower Costs

This module outlines current approaches to population health management, including patient-centered medical homes (PCMHs), perioperative surgical homes (PSHs), and accountable care organizations (ACOs). The module also discusses the implications of population health management for biopharmaceutical and device companies.

EHRs and Health Information Technology: Opportunities for Sales and Marketing

This module looks at how legislation set the wheels in motion. It explores how the use of HIT is being fueled by the adoption of “meaningful use” (now known as “promoting interoperability”) certified electronic health records (EHRs) and discusses the challenges associated with implementing EHRs. This module also clarifies the difference between EHRs and electronic medical records (EMRs), which arrived on the scene in many clinical practices before the nationwide commitment to EHRs.

Inside the C-Suite: Getting a Seat at the Table (Medical Device and Diagnostics)

This module explains how integrated care organizations are reshaping the way MD&D sales teams conduct business. Then it describes a sales process that will help you succeed in the C-Suite environment.

Inside the C-Suite: the Lay of the Land (Medical Device and Diagnostics)

This module provides the foundation you need to succeed in the C-Suite environment. It examines the types of healthcare organizations that comprise a C-Suite target audience and identifies the key goals they share. It also profiles the C-Suite occupants and discusses how their individual goals connect with those of their organization.

Value-Based Care and the Changing Healthcare Delivery Model (Medical Device and Diagnostics)

Employers, health plans, government agencies, and consumers want to make sure that providers are delivering the highest quality care at the lowest cost possible. As a result, physicians, hospitals, and other providers are under tremendous pressure to move away from their traditional payment and delivery approaches, which are based on service volume, to newer, risk-based models that reward providers for value. This module discusses different types of value-based payment and how providers are preparing for the transition from fee-for-service medicine to value-based care. Sales representatives will gain insight into how they can be valued partners by offering products and services that support their customers’ focus on value.

Selling in a Hospital Environment (Medical Device and Diagnostics)

This module explores today’s changing hospital environment and what it means for selling products and services. Throughout, you will be asked to consider the impact to your own accounts.

Integrated Delivery Networks and Accountable Care Organizations (Medical Device and Diagnostics)

This module focuses on the increased integration and consolidation occurring among provider organizations. Hospitals, physicians, and other providers are partnering to better ensure they can provide high-quality, lower-cost care in a coordinated manner across the care continuum (eg, primary care, specialty care, hospital care, post-acute care). At the same time, there is increasing competition among providers for contracts with commercial payers and employers, which are looking to form networks of care with those providers that can deliver value (quality ÷ costs) to patient populations.